Sonidegib M48-[d4]

Sonidegib M48-[d4] is a labelled metabolite of Sonidegib. Sonidegib is an orally bioavailable small-molecule Smoothened (Smo) antagonist with potential antineoplastic activity. It was approved by the FDA for treating basal-cell carcinoma in July 2015.
Supplier BOC Sciences
Product # BLP-004260
Pricing Inquire
Molecular Weight 300.27
Molecular Formula C15H7D4F3O3
Feedback